Calcimimetic R-568 and Its Enantiomer S-568 Increase Nitric Oxide Release in Human Endothelial Cells

Vascular actions of calcimimetics: role of Ca2+-sensing receptors versus Ca2+ influx through L-type Ca2+ channels

(2010) Pratish Thakore et al.   BRITISH JOURNAL OF PHARMACOLOGY

Acute cardiovascular effects of the calcimimetic R-568 and its enantiomer S-568 in rats

(2009) Kumiko Nakagawa et al.   PEDIATRIC NEPHROLOGY

Treatment of Persistent Hyperparathyroidism in Renal Transplant Patients With Cinacalcet Improves Control of Blood Pressure

(2009) F.R. Carrasco et al.   TRANSPLANTATION PROCEEDINGS

Evidence for the presence of GPRC6A receptors in rat mesenteric arteries

(2008) Erika Harno et al.   CELL CALCIUM

Treatment of Secondary Hyperparathyroidism in CKD Patients with Cinacalcet and/or Vitamin D Derivatives

(2008) T. B. Drueke et al.   Clinical Journal of the American Society of Nephrology

The new role of calcimimetics as vasculotropic agents

(2008) Ziyad Al-Aly   KIDNEY INTERNATIONAL

A calcimimetic (R-568), but not calcitriol, prevents vascular remodeling in uremia

(2008) Nadezda Koleganova et al.   KIDNEY INTERNATIONAL